Wickman
Job 19:25
- Joined
- May 14, 2014
- Messages
- 22,161
- Likes
- 30,152
I’m not as against Sark as some of you. It is what it is.
Really like NRZ, especially in that space. I know our research had a price target of $20/share on it at end of Q3 when it was in the $17 range, now I think it’s in the low teens.@NochNoch any thoughts on $NRZ ? $SMG? I fundamentally like Scott’s as a cannabis play without having to deal with cannabis. Dividend is also nice.
Also I’ve been patently against owning PM and by extension Altria because tobacco, but PM is knocking on 7% dividend yield with obvious growth upside.